Golden State Medical Supply recalls Niacin extended-release 1,000 mg tablets because they failed dissolution testing
The tablets failed dissolution specifications, which means they may not dissolve in the body the way they are meant to, and 24,869 bottles were sold nationwide in the USA.
What to do
The notice does not give instructions. Read the official notice for details.
Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.
Recall details
- Product
- NIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals, Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274. Packaged by GSMS, Incorporated, Carmarillo, CA 93012. NDC: 51407-268-90
- Hazard
- Failed Dissolution Specifications
- Units
- 24,869 bottles
- Where sold
- Nationwide in the USA
- FDA classification
- Class II · Ongoing
- Classified by FDA
- November 19, 2025
- Recall started
- October 20, 2025
- FDA enforcement report
- November 26, 2025
- Identifiers
- Codes: Lot, expiry: GS044385, exp 10/2025 ; GS044979, exp 10/2025 ; GS045797, exp 12/2025 ; GS046415, exp 12/2025 ; GS047197, exp 02/2026 ; GS047786, exp 02/2026 ; GS048477, exp 02/2026 ; GS049480, exp 03/2026 ; GS048873, exp 03/2026 ; GS049733, exp 03/2026 ; GS050224, exp 03/2026 ; GS050721, exp 03/2026 ; GS050722, exp 03/2026 ; GS051145, exp 03/2026 ; GS051726, exp 03/2026 ; GS052484, exp 03/2026 ; GS053612, exp 04/2026 ; GS054987, exp 05/2026 ; GS054409, exp 05/2026 ; GS055697, exp 05/2026 ; GS056192, exp 05/2026 ; GS056886, exp 05/2026 ; GS058077, exp 05/2026 ; GS057330, exp 05/2026
- FDA recall number: D-0158-2026
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from FDA.
- Product
- NIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals, Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274. Packaged by GSMS, Incorporated, Carmarillo, CA 93012. NDC: 51407-268-90
- Reason for recall
- Failed Dissolution Specifications
- Classification
- Class II (Ongoing)
- Distribution
- Nationwide in the USA
- Quantity
- 24,869 bottles
Related recalls
Golden State Medical Supply recalls Prasugrel 10mg tablets because they failed dissolution testing
The manufacturer reported that a lot of these tablets failed dissolution testing, meaning the tablets may not dissolve as they should.
Golden State Medical Supply Inc. · 6791 30-count bottles
Golden State Medical Supply recalls primidone tablets over contamination with another drug's ingredient
The active ingredient in these primidone tablets, a prescription medicine, was contaminated with trace amounts of the ingredient acemetacin from another product.
Golden State Medical Supply Inc. · 10,146 units
Golden State Medical Supply recalls carbamazepine 200mg tablets over black specks found in the tablets
Some carbamazepine tablets, used as a prescription medicine, were found with black specks because of manufacturing practice problems, and 1200 bottles were sold nationwide in the USA.
Golden State Medical Supply Inc. · 1200 bottles
Lannett recalls Niacin Extended-release Tablets, USP, 1,000 mg because they failed dissolution specifications
The recalled 90-count bottles of Niacin Extended-release Tablets, USP, 1,000 mg failed dissolution specifications, and the notice does not say what this could do to a person.
Lannett Company Inc. · 46,848 90-count bottles
Lannett recalls Niacin Extended-release Tablets 1,000 mg over failed dissolution test
During stability testing, the tablets failed a dissolution test at the 24-hour timepoint, with results coming in too low, so they did not meet the required release specifications.
Lannett Company Inc. · 3984 bottles